# Impacts of salt restriction on nutritional status, sarcopenia, and mortality of cirrhotic patients with ascites

**Authors:** Maha Elsabaawy, Mohammed Ragab, Madiha Naguib, Eman Kamal, Maymona Al-Khalifa, Khaled Gamil, Marwa Elfayoumy

PMC · DOI: 10.1186/s12876-025-03830-1 · 2025-07-15

## TL;DR

Restricting salt helps control fluid buildup in cirrhotic patients but may worsen nutrition, increase muscle loss, and raise death risk.

## Contribution

This study shows that salt restriction, while effective for ascites, is linked to higher sarcopenia and mortality in cirrhotic patients.

## Key findings

- Salt-restricted patients had better ascites control but more frequent paracentesis.
- Sarcopenia was more common in the salt-restricted group with lower muscle mass indicators.
- Salt restriction was an independent predictor of higher six-month mortality.

## Abstract

Salt restriction is a cornerstone in managing ascites in cirrhotic patients; however, its impact on nutritional status, sarcopenia, and mortality remains unclear.

To evaluate the effects of a salt-restricted diet (SRD) on ascites control, body composition, sarcopenia development, and patient survival in cirrhotic patients with decompensated liver disease.

This prospective study included 102 patients with grade III ascites, categorized into two groups based on dietary adherence: Salt-Restricted Diet (SRD), (n = 46) and Salt-Unrestricted Diet (SUD) (n = 56). Sodium intake was assessed using the Dietary Sodium Restriction Questionnaire (DSRQ) and spot urine Na/K ratio. Nutritional status, sarcopenia, ascites control, and six-month mortality were evaluated.

The SRD group showed better ascites control, with fewer paracentesis sessions per month (1.57 ± 0.65 vs. 4.07 ± 1.43, p < 0.001). Sarcopenia was more prevalent in the SRD group (p < 0.001), with lower SMI (4.88 ± 7.13 vs. 16.7 ± 544.8, p < 0.001) and TR PMM (19.03 ± 3.68 vs. 71.92 ± 191.9, p < 0.001). Higher nutritional risk was significantly associated with SRD (p = 0.001). Mortality was significantly higher in the SRD group (67.4%) compared to the SUD group (35.7%), p = 0.001. Multivariate analysis identified sarcopenia (OR = 2.684, p = 0.006) and SRD (OR = 1.65, p < 0.001) as independent predictors of mortality.

While effective in ascites control, sodium restriction may compromise nutritional status, heighten sarcopenia risk, and increase mortality, highlighting the need for a more individualized dietary approach.

## Linked entities

- **Diseases:** cirrhosis (MONDO:0005155)

## Full-text entities

- **Diseases:** ascites (MESH:D001201), Sarcopenia (MESH:D055948), liver disease (MESH:D008107), cirrhotic (MESH:D000094724), Mortality (MESH:D003643)
- **Chemicals:** Na (MESH:D012964), Salt (MESH:D012492), K (MESH:D011188)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12261796/full.md

---
Source: https://tomesphere.com/paper/PMC12261796